“Global Immunochemistry Reagents, Analyzers and Test Kits market set to grow to $34bn by 2024” says Visiongain report
01 October 2019
Visiongain has launched a new pharma report Immunochemistry Reagents, Analyzers and Test Kits Market: Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers.
Immunochemistry technologies have evolved significantly over the years and now offer critical testing in all areas. High incidences of cancer, infectious diseases and cardiovascular diseases globally will fuel the demand for better disease specific immunochemistry tests.
The lead analyst of the report commented "Established markets such as the US and Western Europe dominate the global immunochemistry market. However, these markets are restrained by reduced healthcare budgets and increased regulatory pressures on device development and approval, which now requires evidence of clinical cost-effectiveness before approval is given.
There is therefore more opportunity for market penetration and larger sales volumes in emerging countries, such as India and China, as these countries remain relatively under penetrated and their diagnostic testing markets offer huge opportunities, especially with the vast population pool."
Leading companies featured in the report include Abbott, bioMerieux, Danaher, Fujirebio, Ortho Clinical Diagnostics, Roche, Siemens, Sysmex Corporation, Thermo Fisher Scientific, Trivitron Healthcare Pvt. Ltd. and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.
About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Recent News
Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034
The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034
26 March 2024
Read
Visiongain Publishes Medical Imaging Devices Market Report 2024-2034
The global Medical Imaging Devices market was valued at US$ 54.3 billion in 2024 and is projected to grow at a CAGR of 4.6% during the forecast period 2024-2034.
20 March 2024
Read
Visiongain Publishes Women’s Health Market Report 2024-2034
The global Women’s Health market was estimated to be valued at US$ 61 billion in 2034 and is expected to register a CAGR of 4.6% from 2024 to 2034.
18 March 2024
Read
Visiongain Publishes Clinical Trial Supplies Market Report 2024-2034
The global Clinical Trial Supplies market is estimated at US$4,146.7 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period 2024-2034.